Vaccination with T cell-defined antigens: biological basis and clinical applications.
作者信息
Parmiani G
机构信息
Unit of Immunotherapy of Human Tumors, National Cancer Institute, Milan, Italy.
出版信息
Tumori. 2001 Nov-Dec;87(6):S10.
PMID:11989607
Abstract
摘要
相似文献
1
Vaccination with T cell-defined antigens: biological basis and clinical applications.用T细胞定义抗原进行疫苗接种：生物学基础与临床应用。
Tumori. 2001 Nov-Dec;87(6):S10.
2
T cell response to tumor antigens and its therapeutic use in cancer patients.T细胞对肿瘤抗原的反应及其在癌症患者中的治疗应用。
Adv Exp Med Biol. 2001;495:403-10. doi: 10.1007/978-1-4615-0685-0_59.
3
Immunotherapy in non-renal carcinomas.非肾癌的免疫疗法。
Urologe A. 2004 Sep;43 Suppl 3:S138-40. doi: 10.1007/s00120-004-0605-7.
4
Cancer vaccination progress.癌症疫苗接种进展。
Trends Mol Med. 2002 Dec;8(12):545-6. doi: 10.1016/s1471-4914(02)02430-9.
5
Tumor-specific antigens and immunologic adjuvants in cancer immunotherapy.肿瘤特异性抗原和免疫佐剂在癌症免疫治疗中的应用。
Cancer J. 2011 Sep-Oct;17(5):325-30. doi: 10.1097/PPO.0b013e3182326004.
6
Peptide-based vaccines for cancer therapy.用于癌症治疗的肽基疫苗。
Hum Vaccin Immunother. 2014;10(11):3175-8. doi: 10.4161/hv.29418.
7
[General principles and first clinical trials of therapeutic vaccines against cancer].[癌症治疗性疫苗的一般原则及首次临床试验]
Bull Cancer. 2008 Mar;95(3):327-35. doi: 10.1684/bdc.2008.0588.
8
How much help does a vaccine-induced T-cell response need?疫苗诱导的T细胞反应需要多大程度的帮助？
J Clin Invest. 2001 Mar;107(5):553-4. doi: 10.1172/JCI12403.
9
Randomized clinical studies of anti-tumor vaccination: state of the art in 2008.抗肿瘤疫苗的随机临床研究：2008年的最新进展
Expert Rev Vaccines. 2009 Jan;8(1):51-66. doi: 10.1586/14760584.8.1.51.
10
[Perspectives for tumour immunology: antigen-specific immunotherapy of malignant diseases].[肿瘤免疫学展望：恶性疾病的抗原特异性免疫疗法]
Dtsch Med Wochenschr. 2001 Sep 14;126(37):1011-6. doi: 10.1055/s-2001-17111.
Zotero 插件